Atlas Trials

NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)

Clinical trial NCT01092858 · TERMINATED

Trial details

NCT number
NCT01092858
Sponsor
Bayer
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypogonadism
Start date
2010-09-01
Primary completion
2011-07-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.